Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of Archives of Neurology, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The AMA designates this educational activity for up to 3 hours of category 1 CME credit per Archives of Neurology issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim only those hours of credit that were actually spent in this educational activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is only available to physicians licensed in the United States, Canada, or Mexico.
Statement of Educational Purpose
The Archives of Neurology provides new evidence for the practice of neurology, neurosurgery, and other specialties whose goal is to improve the neurological health of all people. Original contributions, neurological reviews, neurology and public health, and history of neurology are among the categories of articles published, but all contributions receive a sympathetic reading by the Chief Editor. The journal's editorial board sets the initial framework for the types of articles published, which is then modified by feedback from editors, external peer reviewers, authors, and readers. We are keen to receive submissions from practicing neurologists to provide new insight for colleagues.
We want our readers to assess each article critically; this CME activity is active, not passive. Does the article contribute in some way to the practice of neurology? How could you modify your practice style to incorporate what you have learned? How can you acquire more information, challenge the authors' conclusions, or verify what you have read? Which of the articles in each issue is least helpful in your quest for the best and most applicable evidence?
Earning Credit and CME Evaluation Form
To earn 1 hour of category 1 CME credit, you should read any 3 of the CME articles listed below and complete the CME Evaluation Form. To earn 3 hours of credit, read all of the articles listed below and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 4 weeks of the issue date. A certificate awarding up to 3 hours of category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received.
CME Articles in This Issue of Archives of Neurology
The articles listed below may be read for CME credit.
Multiple Sclerosis: Therapeutic Update (SEE ARTICLE)
Educational Objective: To review recent advances in the treatment of multiple sclerosis.
Biomarkers of Alzheimer Disease (SEE ARTICLE)
Educational Objective: To learn about the practical implications of a recent consensus statement that reviewed biomarkers of Alzheimer Disease.
Mutational Analysis and Genotype-Phenotype Correlation of 29 Unrelated Japanese Patients With X-linked Adrenoleukodystrophy (SEE ARTICLE)
Educational Objective: To learn about the neurogenetics of X-linked adrenoleukodystrophy in Japanese patients.
Mild Cognitive Impairment: Clinical Characterization and Outcome (SEE ARTICLE)
Educational Objective: To understand the clinical criteria for mild cognitive impairment.
Elevated Levels of Antibody to Myelin Oligodendrocyte Glycoprotein Is Not Specific for Patients With Multiple Sclerosis (SEE ARTICLE)
Educational Objective: To realize that the elevated antimyelin oligodendrocyte glycoprotein in the cerebrospinal fluid and plasma of patients with multiple sclerosis is a nonspecific finding.
Neuropsychologic Status in Multiple Sclerosis After Treatment With Glatiramer (SEE ARTICLE)
Educational Objective: To examine the effects of glatimer acetate on neuropsychologic function in patients with relapsing-remitting multiple sclerosis.
Brain Proton Magnetic Resonance Spectroscopy and Brain Atrophy in Myotonic Dystrophy (SEE ARTICLE)
Educational Objective: To study cerebral alterations in myotonic dystrophy with magnetic resonance imaging and spectroscopy.
Progression of Parkinsonian Signs in Parkinson Disease (SEE ARTICLE)
Educational Objective: To examine the progression of extrapyramidal signs in Parkinson disease in a community-based study.
Prefrontal Gray and White Matter Volumes in Healthy Aging and Alzheimer Disease (SEE ARTICLE)
Educational Objective: To evaluate whether prefrontal tissue volumes have diagnostic usefulness in patients with Alzheimer disease.
Development of Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Images in Multiple Sclerosis: Relation to Inflammatory Activity (SEE ARTICLE)
Educational Objective: To examine the prognostic value of magentic resonance imaging findings in patients with multiple sclerosis.
The Exercise Test in Andersen Syndrome (SEE ARTICLE)
Educational Objective: To study the clinical usefulness of an exercise test to confirm the diagnosis of periodic paralysis in Andersen syndrome.
Creutzfeldt-Jakob Disease With Florid-Type Plaques After Cadaveric Dura Mater Grafting (SEE ARTICLE)
Educational Objective: To examine the clinicopathological correlations of dura-associated Creutzfeldt-Jakob disease.
